2025-09-19 - Analysis Report
Okay, let's analyze Intuitive Surgical (ISRG) based on the data provided. Here's a report structured as you requested, with a focus on concise summaries and key takeaways:

**Report: Intuitive Surgical Inc. (ISRG) Analysis**

**Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

**1. Performance vs. S&P 500 (VOO)**

*   **ISRG Cumulative Return:** 86.94%
*   **VOO Cumulative Return:** 106.00%
*   **Absolute Deviation:** -11.6%
*   **Relative Deviation:** 0.0% (This indicates ISRG is currently at the low end of its historical deviation range compared to VOO).

**Alpha, Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|------|--------|
| 2015-2017  | 68.0% | 56.5% | 39.0% | 0.0  | 43.6   |
| 2016-2018  | 77.0% | 63.4% | 59.0% | 0.0  | 57.2   |
| 2017-2019  | 81.0% | 63.4% | 52.0% | 0.3  | 70.6   |
| 2018-2020  | 47.0% | 63.4% | 28.0% | 0.2  | 97.8   |
| 2019-2021  | 91.0% | 63.0% | 43.0% | 0.2  | 128.8  |
| 2020-2022  | -3.0% | 69.9% | -6.0% | 0.2  | 95.1   |
| 2021-2023  | -5.0% | 72.9% | -23.0% | 0.9  | 120.9  |
| 2022-2024  | 26.0% | 72.9% | 0.0%  | 0.9  | 187.1  |
| 2023-2025  | 8.0%  | 72.9% | -50.0% | 0.7  | 156.2  |

*   **Analysis:** While ISRG has demonstrated strong growth in the past, recent periods (2020-2025) show lower CAGR and negative Alpha, indicating underperformance relative to the market. Beta has increased more recently, suggesting higher market sensitivity.

**2. Recent Stock Price Movement**

*   **Current Price:** $435.83
*   **Previous Close:** $433.66 (Slight increase: 0.5%)
*   **5-Day Moving Average:** $437.53
*   **20-Day Moving Average:** $457.49
*   **60-Day Moving Average:** $488.07

*   **Analysis:** The current price is below all moving averages, suggesting a short-term downtrend. The slight price increase today could be a sign of stabilization, but more data is needed.

**3. Technical Indicators & Expected Return**

*   **MRI:** 0.3324 (Low Risk)
*   **RSI:** 33.14 (Oversold)
*   **PPO:** -0.4188
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.33)
*   **Delta_Previous_Relative_Divergence:** -5.4 (Short-term decrease)
*   **Expected Return:** 4569.6% (Long-term, relative to S&P 500)
*   **Analysis:** The RSI indicates that the stock may be oversold and potentially due for a rebound. The negative PPO confirms the short-term downtrend. The MRI suggests a low-risk environment. The significant 'Expected Return' suggests strong long-term growth potential, although this is a highly speculative figure. The relatively large single day change could be signaling a potential change in direction.

**4. Recent News & Events**

*   **Key Themes:** Analyst optimism (Bernstein, Bank of America) with "Outperform" and "Buy" ratings, Long-term investment potential highlighted (Motley Fool), da Vinci 5 introduction despite stock dip (Zacks).
*   **Takeaway:**  Positive analyst sentiment and long-term bullish outlook offset by immediate market reaction to news.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (1.94 on scale)
*   **Target Price:** $582.10 (Average)
*   **Analysis:**  Analysts are generally positive on ISRG, with an average target price significantly above the current price. No recent rating changes were provided.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2024-07-19 | 1.48 | 2.01 B$   |
| 2025-07-23 | 1.48 | 2.01 B$   |

*   **Analysis:** EPS and Revenue have generally been increasing. However, there is a duplicate entry for 2025-07-23, which needs clarification.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $2.44B  | 66.31%        |
| 2025-03-31 | $2.25B  | 64.69%        |
| 2024-12-31 | $2.41B  | 68.04%        |
| 2024-09-30 | $2.04B  | 67.41%        |
| 2024-06-30 | $2.01B  | 68.30%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2025-06-30 | $17.85B  | 3.69%   |
| 2025-03-31 | $17.11B  | 4.08%   |
| 2024-12-31 | $16.43B  | 4.17%   |
| 2024-09-30 | $15.58B  | 3.63%   |
| 2024-06-30 | $14.71B  | 3.58%   |

*   **Analysis:** Revenue and Equity are on an upward trend. Profit Margins are consistently high. ROE fluctuates but is within a reasonable range.

**7. Overall Summary**

Intuitive Surgical (ISRG) is currently experiencing a short-term downtrend, as indicated by its price relative to moving averages and technical indicators. However, the RSI suggests it may be oversold. Analyst sentiment remains positive, and long-term growth prospects are considered strong. The company exhibits solid financial performance with growing revenue, high-profit margins, and increasing equity.

**Key Considerations:**

*   **Recent Underperformance:** ISRG has underperformed the S&P 500 recently.
*   **Analyst Optimism vs. Market Reaction:**  Pay attention to the disconnect between positive analyst ratings and the stock's immediate reaction to news (e.g., da Vinci 5 launch).
*   **Long-Term Potential:**  The company's strong fundamentals, growth in robotic surgery, and positive long-term analyst outlook suggest potential for future appreciation.

**Recommendation:**

While the stock is currently facing headwinds, the combination of oversold conditions, positive analyst sentiment, and strong fundamentals suggests that ISRG may be a worthwhile investment for long-term investors. However, potential investors should be aware of the recent underperformance and the volatile market conditions.
